Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10015083HBVENSG00000172296.13protein_codingSPTLC3NoNo55304Q9NUV7
TVIS10015084HBVENSG00000172296.13protein_codingSPTLC3NoNo55304Q9NUV7
TVIS10015085HBVENSG00000172296.13protein_codingSPTLC3NoNo55304Q9NUV7
TVIS10015086HBVENSG00000172296.13protein_codingSPTLC3NoNo55304Q9NUV7
TVIS10028976HBVENSG00000172296.13protein_codingSPTLC3NoNo55304Q9NUV7
TVIS10028977HBVENSG00000172296.13protein_codingSPTLC3NoNo55304Q9NUV7
TVIS10028978HBVENSG00000172296.13protein_codingSPTLC3NoNo55304Q9NUV7
TVIS10028979HBVENSG00000172296.13protein_codingSPTLC3NoNo55304Q9NUV7
TVIS10028980HBVENSG00000172296.13protein_codingSPTLC3NoNo55304Q9NUV7
TVIS10028981HBVENSG00000172296.13protein_codingSPTLC3NoNo55304Q9NUV7
TCGA Plot Options
Drug Information
GeneSPTLC3
DrugBank IDDB00114
Drug NamePyridoxal phosphate
Target IDBE0002172
UniProt IDQ9NUV7
Regulation Typecofactor
PubMed IDs22616865; 12782147; 19648650; 19416851
CitationsLowther J, Naismith JH, Dunn TM, Campopiano DJ: Structural, mechanistic and regulatory studies of serine palmitoyltransferase. Biochem Soc Trans. 2012 Jun 1;40(3):547-54. doi: 10.1042/BST20110769.@@Hanada K: Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta. 2003 Jun 10;1632(1-3):16-30.@@Hornemann T, Penno A, Rutti MF, Ernst D, Kivrak-Pfiffner F, Rohrer L, von Eckardstein A: The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. J Biol Chem. 2009 Sep 25;284(39):26322-30. doi: 10.1074/jbc.M109.023192. Epub 2009 Aug 1.@@Han G, Gupta SD, Gable K, Niranjanakumari S, Moitra P, Eichler F, Brown RH Jr, Harmon JM, Dunn TM: Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc Natl Acad Sci U S A. 2009 May 19;106(20):8186-91. doi: 10.1073/pnas.0811269106. Epub 2009 May 5.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationPyridoxals and derivatives
SMILESCC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
PathwaysHistidinemia; 3-Methylglutaconic Aciduria Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); beta-Ketothiolase Deficiency; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Argininosuccinic Aciduria; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Porphyrin Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Taurine and Hypotaurine Metabolism; Catecholamine Biosynthesis; Glycine and Serine Metabolism; Carnitine Synthesis; Tyrosinemia Type 3 (TYRO3); Selenoamino Acid Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Globoid Cell Leukodystrophy; Ammonia Recycling
PharmGKBPA164749650
ChEMBLCHEMBL82202